RepliCel Life Sciences Inc.

RepliCel signs Letter of Intention (Asset Purchase) replicel.com/news/letter-of…

RepliCel Shareholders are invited to attend the AGM located at Clark Wilson LLP 900 – 885 West Georgia Street Vancouver, BC V6C 3H1 on September 22 at 2 PM Pacific. The AGM Zoom Link and Materials are posted on the RepliCel website located at replicel.com

@Takeagander02 No worries, we will post the Zoom access link on the website on September 22 before the meeting at 2 p.m. PST. We will place it on the main page for your convenience.

@RepliCel Decided to delete your prior tweet with Zoom dial-in???

Shareholders are invited to the RepliCel AGM scheduled for September 22 at 2 p.m. PST. We hope you can join in person at Clark Wilson LLP located at 900 – 885 West Georgia Street Vancouver, BC V6C 3H1 or see website before meeting for online access.

In response to investor inquiries, RepliCel notes that the arbitration proceedings with Shiseido are ongoing. RepliCel respects the confidentiality rules of the ICDR and will provide material updates as they become available. We thank investors for their ongoing interest!

For more info visit the EHRS website here: ehrs2023.com

CEO, Andrew Schutte and Chief Science Officer, Kevin McElwee attended the European Hair Research Society Biannual Conference in Sheffield, UK! Great connections and progress towards developing RCH-01 for Androgenetic Alopecia. We received a lot of interest in our functional commercial grade Dermaprecise injector. Thank you to the EHRS organizers for a fantastic event, many of whom we are collaborating with. @researchhair @ehrs2023 #curebalding

RepliCel notes that the proceedings are ongoing and will further elaborate as circumstances allow. RepliCel is committed to commercializing RCH-01! RepliCel aims to have a fully calibrated commercial grade device in the coming months. We look forward to updating the market as material events unfold. #hairloss #innovation #progress

Thank you for attending our AGM! The two big takeaways that our CEO, Andrew Schutte, expressed are: 1) Obtaining a 510k approval for DermaPrecise this year 2) Concluding our ongoing arbitration proceedings, the hearing begins May 29th.

I’m en route to Canada 🇨🇦 today for @RepliCel AGM and meetings with scientists and business peeps. Of course I am flying by #hairplane ! 🌎🛩️🍁🔬🧫😁

Wrapping up a productive day with ⁦@RepliCel⁩ and ⁦@ResearchHair⁩. Lots of science and planning for future collaborations.

RepliCel’s AGM is scheduled for February 28,2023 at 2 pm PST. It will be held in person at our legal office at Clark Wilson 900-855 West Georgia St. Vancouver BC, & virtually via Zoom. Our President & CEO Andrew Schutte will present alongside the Directors. Hope to see you there!

We are back from our trip to Japan. 🇯🇵 RepliCel is planning another visit to Japan in a few weeks. We are making progress and we won’t stop.

We just arrived in Japan! We are meeting with multiple potential investors and partners for all of our products: RCH-01 for regrowing hair, RCS-01 for rejuvenating skin, RCT-01 for repairing tendons,& DermaPrecise for precision injections. CEO Andrew Schutte is busy. Stay tuned.

RepliCel Provides Corporate Update replicel.com/news/replicel-…

@takeagander01 @DermaPrecise 4-5 years is clearly an exaggeration. The partnership is not dead by any means but moving forward has been very slow in China since COVID hit. Regulatory clearance for clinical studies is still pending. Launch of @DermaPrecise in Hong Kong after FDA approval is now our next goal.

@RepliCel @DermaPrecise Hey Lee & Team - what’s the latest with YOFOTO? You guys haven’t shared an update on this in like 4-5 years… is this partnership dead in the water?

The @DermaPrecise Injection System Shown to Produce Consistently High Cell Viability for Cell Therapy Injections. Testing performed by Innovacell shows cell data superior using the DermaPrecise injector vs manual injections. accesswire.com/viewarticle.as… #celltherapy #dermtwitter

How many papers might the new White House public access policy apply to? OSTP estimates 195,000 to 263,000 articles fed funded in 2020. That is ~7% to 9% of the 2.9 million papers published worldwide in 2020. From: p12 of economic analysis to Congress. whitehouse.gov/wp-content/upl…

Great news for science transparency and the democratization of research data!